Skip to main content

HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the influence of technology and socio-economic status on HbA1c in the T1D Exchange Clinic Registry Findings.

Citation
Miller, K. M., et al. “Hba1C Levels In Type 1 Diabetes From Early Childhood To Older Adults: A Deeper Dive Into The Influence Of Technology And Socio-Economic Status On Hba1C In The T1D Exchange Clinic Registry Findings.”. Diabetes Technology & Therapeutics.
Center Stanford University
Author Kellee M Miller, Roy W Beck, Nicole C Foster, David M Maahs
Abstract

OBJECTIVE: The T1D Exchange Clinic Registry figure of HbA1c levels according to age has become a classic picture of how average HbA1c varies from childhood to elderly. To further assess the course of HbA1c across the life span in T1D, we created similar figures stratified by device use and socio-economic status (SES).

METHODS: Mean HbA1c was plotted versus age for 21,253 T1D Exchange Clinic Registry participants with an HbA1c measurement between January 1, 2016 and March 31, 2018 according to device use, race-ethnicity, and measures of SES.

RESULTS: Across the age range from childhood to elderly, CGM use without an insulin pump had better average HbA1c than pump without CGM; and among CGM users, pump and injection users had similar HbA1c levels. Any device use (pump or CGM) was associated with better HbA1c levels than no device use across the age range. Lower SES and African American race were associated with higher HbA1c across the age range. Across all device use, SES, and race-ethnicity factors, average HbA1c levels were highest in adolescents and young adults.

CONCLUSION: Although the plot of average HbA1c from early childhood to elderly shifts according to device use and SES factors, the shape of the plots remain reasonably constant with highest HbA1c levels in adolescents and young adults. These findings emphasize the importance of targeting adolescence and early adulthood as the ages with the greatest need for improving diabetes management irrespective of device use and SES.

Year of Publication
2020
Journal
Diabetes technology & therapeutics
Date Published
01/2020
ISSN Number
1557-8593
DOI
10.1089/dia.2019.0393
Alternate Journal
Diabetes Technol. Ther.
PMID
31905008
Download citation